The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 15, 2022
Filed:
Apr. 28, 2017
Applicant:
Fgh Biotech, Inc., Houston, TX (US);
Inventors:
Assignee:
FGH BIOTECH, INC., Houston, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4439 (2006.01); C07D 305/08 (2006.01); C07D 231/12 (2006.01); C07D 401/14 (2006.01); C07D 401/04 (2006.01); C07D 307/22 (2006.01); A61P 3/00 (2006.01); A61P 9/00 (2006.01); A61P 35/00 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 31/506 (2013.01); A61P 3/00 (2018.01); A61P 9/00 (2018.01); A61P 35/00 (2018.01); C07D 231/12 (2013.01); C07D 305/08 (2013.01); C07D 307/22 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01);
Abstract
Provided herein are compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions in treating a condition, disease, or disorder associated with abnormal activation of the SREBP pathway, including metabolic disorders such as obesity, cancer, cardiovascular disease, and nonalcoholic fatty liver disease (NAFLD) wherein the compound is according to Formula (I).